1. Home
  2. PAYC vs ROIV Comparison

PAYC vs ROIV Comparison

Compare PAYC & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paycom Software Inc.

PAYC

Paycom Software Inc.

HOLD

Current Price

$160.62

Market Cap

8.9B

Sector

Technology

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

BUY

Current Price

$21.66

Market Cap

14.1B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
PAYC
ROIV
Founded
1998
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
14.1B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
PAYC
ROIV
Price
$160.62
$21.66
Analyst Decision
Buy
Strong Buy
Analyst Count
14
8
Target Price
$220.31
$24.31
AVG Volume (30 Days)
745.4K
8.2M
Earning Date
02-11-2026
02-09-2026
Dividend Yield
0.94%
N/A
EPS Growth
N/A
N/A
EPS
8.05
N/A
Revenue
$2,001,300,000.00
$20,329,000.00
Revenue This Year
$11.03
N/A
Revenue Next Year
$8.80
$741.42
P/E Ratio
$19.93
N/A
Revenue Growth
9.72
N/A
52 Week Low
$156.50
$8.73
52 Week High
$267.76
$23.47

Technical Indicators

Market Signals
Indicator
PAYC
ROIV
Relative Strength Index (RSI) 40.48 52.70
Support Level $158.86 $21.60
Resistance Level $166.36 $22.72
Average True Range (ATR) 3.75 0.83
MACD 0.36 -0.07
Stochastic Oscillator 17.74 45.58

Price Performance

Historical Comparison
PAYC
ROIV

About PAYC Paycom Software Inc.

Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: